Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry
We sought to determine the clinicopathological significance of PD-1, LAG3, and TIM3 in gastric cancer (GC) by examining their expression and immune context. Immunohistochemistry (IHC) for PD-1, TIM3, LAG3, and tumor-infiltrating immune cell (TIIC) markers was performed in 385 stage II/III GCs. Epste...
Main Authors: | Yujun Park, An Na Seo, Jiwon Koh, Soo Kyoung Nam, Yoonjin Kwak, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Hye Seung Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2021.1954761 |
Similar Items
-
Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma
by: Felix C. Popp, et al.
Published: (2021-05-01) -
Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer
by: An-Ping Shi, et al.
Published: (2022-01-01) -
Histopathological Evaluation of LAG-3, TIM-3 AND CD38 Levels in Meningiomas
by: Uzay Erdoğan, et al.
Published: (2021-12-01) -
LAG3: The Biological Processes That Motivate Targeting This Immune Checkpoint Molecule in Human Cancer
by: Cinzia Solinas, et al.
Published: (2019-08-01) -
LAG-3 Inhibitors: Novel Immune Checkpoint Inhibitors Changing the Landscape of Immunotherapy
by: Rebecca Ibrahim, et al.
Published: (2023-07-01)